Ainos, Inc. (NASDAQ:AIMD) Sees Significant Increase in Short Interest

Ainos, Inc. (NASDAQ:AIMD) saw a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 634,100 shares, a growth of 258.0% from the December 31st total of 177,100 shares. Based on an average trading volume of 621,400 shares, the days-to-cover ratio is currently 1.0 days. Currently, 14.5% of the shares of the company are sold short.

Ainos Trading Down 3.9 %

AIMD stock opened at $0.68 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.37 and a quick ratio of 1.33. The stock’s fifty day simple moving average is $0.54 and its two-hundred day simple moving average is $0.56. Ainos has a 1-year low of $0.40 and a 1-year high of $3.10.

Ainos (NASDAQ:AIMD) last released its earnings results on Wednesday, November 6th. The company reported ($0.33) EPS for the quarter.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.